172 related articles for article (PubMed ID: 23142226)
1. STEAP1 is overexpressed in cancers: a promising therapeutic target.
Moreaux J; Kassambara A; Hose D; Klein B
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):148-55. PubMed ID: 23142226
[TBL] [Abstract][Full Text] [Related]
2. STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors.
Grunewald TG; Diebold I; Esposito I; Plehm S; Hauer K; Thiel U; da Silva-Buttkus P; Neff F; Unland R; Müller-Tidow C; Zobywalski C; Lohrig K; Lewandrowski U; Sickmann A; Prazeres da Costa O; Görlach A; Cossarizza A; Butt E; Richter GH; Burdach S
Mol Cancer Res; 2012 Jan; 10(1):52-65. PubMed ID: 22080479
[TBL] [Abstract][Full Text] [Related]
3. STEAP proteins: from structure to applications in cancer therapy.
Gomes IM; Maia CJ; Santos CR
Mol Cancer Res; 2012 May; 10(5):573-87. PubMed ID: 22522456
[TBL] [Abstract][Full Text] [Related]
4. Six-transmembrane epithelial antigen of the prostate as an immunotherapeutic target for renal cell and bladder cancer.
Azumi M; Kobayashi H; Aoki N; Sato K; Kimura S; Kakizaki H; Tateno M
J Urol; 2010 May; 183(5):2036-44. PubMed ID: 20303532
[TBL] [Abstract][Full Text] [Related]
5. Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET.
Doran MG; Watson PA; Cheal SM; Spratt DE; Wongvipat J; Steckler JM; Carrasquillo JA; Evans MJ; Lewis JS
J Nucl Med; 2014 Dec; 55(12):2045-9. PubMed ID: 25453051
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Role of STEAP1 Expression Determined via Immunohistochemistry Staining in Predicting Prognosis of Primary Colorectal Cancer: A Survival Analysis.
Lee CH; Chen SL; Sung WW; Lai HW; Hsieh MJ; Yen HH; Su TC; Chiou YH; Chen CY; Lin CY; Chen ML; Chen CJ
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104516
[TBL] [Abstract][Full Text] [Related]
7. Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer.
Nakamura H; Takada K; Arihara Y; Hayasaka N; Murase K; Iyama S; Kobune M; Miyanishi K; Kato J
Cancer Gene Ther; 2019 Sep; 26(9-10):313-322. PubMed ID: 30401882
[TBL] [Abstract][Full Text] [Related]
8. STEAP1 is over-expressed in breast cancer and down-regulated by 17beta-estradiol in MCF-7 cells and in the rat mammary gland.
Maia CJ; Socorro S; Schmitt F; Santos CR
Endocrine; 2008; 34(1-3):108-16. PubMed ID: 18958632
[TBL] [Abstract][Full Text] [Related]
9. Six-transmembrane epithelial antigen of the prostate 1 expression promotes ovarian cancer metastasis by aiding progression of epithelial-to-mesenchymal transition.
Jiao Z; Huang L; Sun J; Xie J; Wang T; Yin X; Zhang H; Chen J
Histochem Cell Biol; 2020 Aug; 154(2):215-230. PubMed ID: 32382787
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgens.
Gomes IM; Rocha SM; Gaspar C; Alvelos MI; Santos CR; Socorro S; Maia CJ
Med Oncol; 2018 Feb; 35(3):40. PubMed ID: 29464393
[TBL] [Abstract][Full Text] [Related]
11. Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner.
Kobayashi H; Nagato T; Sato K; Aoki N; Kimura S; Murakami M; Iizuka H; Azumi M; Kakizaki H; Tateno M; Celis E
Cancer Res; 2007 Jun; 67(11):5498-504. PubMed ID: 17545632
[TBL] [Abstract][Full Text] [Related]
12. The STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions.
Grunewald TG; Bach H; Cossarizza A; Matsumoto I
Biol Cell; 2012 Nov; 104(11):641-57. PubMed ID: 22804687
[TBL] [Abstract][Full Text] [Related]
13. Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
Bhatia V; Kamat NV; Pariva TE; Wu LT; Tsao A; Sasaki K; Sun H; Javier G; Nutt S; Coleman I; Hitchcock L; Zhang A; Rudoy D; Gulati R; Patel RA; Roudier MP; True LD; Srivastava S; Morrissey CM; Haffner MC; Nelson PS; Priceman SJ; Ishihara J; Lee JK
Nat Commun; 2023 Apr; 14(1):2041. PubMed ID: 37041154
[TBL] [Abstract][Full Text] [Related]
14. Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges.
Barroca-Ferreira J; Pais JP; Santos MM; Goncalves AM; Gomes IM; Sousa I; Rocha SM; Passarinha LA; Maia CJ
Curr Cancer Drug Targets; 2018; 18(3):222-230. PubMed ID: 28460619
[TBL] [Abstract][Full Text] [Related]
15. [Influence of expression of six transmembrane epithelial antigen of the prostate-1 on intracellular reactive oxygen species level and cell growth: an in vitro experiment].
Pan YZ; Li Y; Guo LR; Zhao YY; Zhao XJ
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(9):641-4. PubMed ID: 18646723
[TBL] [Abstract][Full Text] [Related]
16. CD200: a putative therapeutic target in cancer.
Moreaux J; Veyrune JL; Reme T; De Vos J; Klein B
Biochem Biophys Res Commun; 2008 Feb; 366(1):117-22. PubMed ID: 18060862
[TBL] [Abstract][Full Text] [Related]
17. In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer.
Garcia-Hernandez Mde L; Gray A; Hubby B; Kast WM
Cancer Res; 2007 Feb; 67(3):1344-51. PubMed ID: 17283172
[TBL] [Abstract][Full Text] [Related]
18. Six-transmembrane epithelial antigen of the prostate-1 plays a role for in vivo tumor growth via intercellular communication.
Yamamoto T; Tamura Y; Kobayashi J; Kamiguchi K; Hirohashi Y; Miyazaki A; Torigoe T; Asanuma H; Hiratsuka H; Sato N
Exp Cell Res; 2013 Oct; 319(17):2617-26. PubMed ID: 23916873
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis.
Zhao C; Xiong K; Ji Z; Liu F; Li X
Oxid Med Cell Longev; 2022; 2022():8297011. PubMed ID: 35313641
[TBL] [Abstract][Full Text] [Related]
20. High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patients.
Grunewald TGP; Ranft A; Esposito I; da Silva-Buttkus P; Aichler M; Baumhoer D; Schaefer KL; Ottaviano L; Poremba C; Jundt G; Jürgens H; Dirksen U; Richter GHS; Burdach S
Ann Oncol; 2012 Aug; 23(8):2185-2190. PubMed ID: 22317770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
